Pharmadax Inc (法德生技藥品) yesterday said it has gained marketing approval in China for its generic schizophrenia drug and expects to grab 20 percent of the market within three years.
On Sunday, the company received approval from the Chinese National Medical Products Administration (NMPA) for the 50mg, 150mg, 200mg, 300mg and 400mg versions of its quetiapine fumarate ER tablets, Pharmadax said, adding that its drug is the generic version of AstraZeneca PLC’s Seroquel XR tablet.
The company obtained US Food and Drug Administration (FDA) approval for the antipsychotic drug in 2017.
The US approval helped the firm secure a priority review with the NMPA, which sped up the licensing process to less than two years, Pharmadax said.
While competition has become heated in the US, with a few companies producing generic versions of Seroquel, including Handa Pharmaceuticals Inc (漢達生技) and India’s Lupin Ltd, Pharmadax said that there would be less competition in China.
“Currently, only the original Seroquel is available in China, and we are the first generic drug company to obtain approval, while other companies are still waiting, so we are confident that we can stay ahead of our rivals,” a company official told the Taipei Times.
Sales of quetiapine fumarate tablets in China increased 32.13 percent year-on-year to 1.75 billion yuan (US$244.9 million) last year, Pharmadax said.
With the Chinese government paying more attention to mental health, more health programs or support services are expected to be launched in the country, which would likely boost sales of antipsychotic drugs, the company said.
Pharmadax has set a target of annual sales growth of 50 percent over the next three years, aided by China-based Coland Holdings Ltd (康聯控股), which is responsible for marketing the drug for the next five years.
Coland has set up distribution channels in more than 200 cities and at more than 3,500 hospitals in China, Pharmadax said.
The company said it would begin marketing the drug in China soon, declining to give an exact date.
Pharmadax has finalized the prices for Quetiapine Fumarate with Coland, which would be slightly lower than the original drug, it said.
The company would produce 800 million tablets per year at its two plants in Foshan, Guangdong Province, it added.
Elon Musk’s lieutenants have reached out to chip industry suppliers, including Applied Materials Inc, Tokyo Electron Ltd and Lam Research Corp, for his envisioned Terafab, early steps in an audacious and likely arduous attempt to break into the production of cutting-edge chips. Staff working for the joint venture between Tesla Inc and Space Exploration Technologies Corp (SpaceX) have sought price quotes and delivery times for an array of chipmaking gear, people familiar with the matter said. In past weeks, they’ve contacted makers of photomasks, substrates, etchers, depositors, cleaning devices, testers and other tools, according to the people, who asked not to
Taiwan is attracting a growing number of foreign jobseekers as companies increasingly recruit overseas talent to ease labor shortages and expand global reach, recruitment platform 104 Job Bank (104人力銀行) said yesterday. More than 40,000 foreign nationals searched for jobs in Taiwan through the platform last year, a 28 percent increase from a year earlier, the company said. Malaysians accounted for the largest share of overseas jobseekers at 12.2 percent, followed by Indonesians at 11.9 percent and Vietnamese at 10.8 percent. Indonesian applicants surged more than 50 percent year-on-year, while Vietnamese jobseekers rose by more than 30 percent. Applicants from the
NO SHORTCUTS: Asked about Elon Musk’s Terafab initiative, TSMC CEO C.C. Wei said it takes two to three years to build a fab and another one to two to ramp it up Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday raised its revenue growth forecast for this year to above 30 percent, up from the 25 percent it estimated three months earlier, citing extremely robust artificial intelligence (AI)-related chip demand. “Our customers and customers’ customers, who are mainly cloud service providers, continue to send us very positive signals and outlook,” TSMC chairman and CEO C.C. Wei (魏哲家) said at an earnings conference. The company also hiked its capital expenditure for this year toward the higher end of its forecast, or US$56 billion, as it aims to step up advanced chip capacity expansions, such as
The founder of Chinese property giant Evergrande Group (恆大集團) has pleaded guilty to charges of fraud and bribery, a court said yesterday, the latest blow for what was once the country’s leading developer. Evergrande’s rise was propelled by decades of rapid urbanization and rising living standards, but in 2020, its access to credit dramatically narrowed when the government introduced curbs on excessive borrowing and speculation. The company defaulted in 2021 after struggling to repay creditors. Founder Xu Jiayin (許家印), 67, known as Hui Ka Yan in Cantonese, was reportedly held by police in 2023, with Evergrande saying he had been subjected to
RSS